What is Pulmonx Corporation's net change in cash?

Pulmonx Corporation (LUNG) reported net change in cash of -$8.18M in Q1 2026.

How has Pulmonx Corporation's net change in cash changed year-over-year?

Pulmonx Corporation's net change in cash decreased by 324.1% year-over-year, from $3.65M to -$8.18M.

What is the long-term trend for Pulmonx Corporation's net change in cash?

Over 3 years (2021 to 2025), Pulmonx Corporation's net change in cash has grown at a -76.0% compound annual growth rate (CAGR), from -$83.08M to -$1.15M.

What does net change in cash mean?

Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.

Pulmonx Corporation LUNG Net Change in Cash

Net Change in Cash at other companies

Intuitive SurgicalISRG

-$1.36B-344%

Theravance BiopharmaTBPH

$120.3M+65.2%

SavaraSVRA

$5.61M+26.7%

LQD

Liquidia CorporationLQDA

$32.11M+578%

United TherapeuticsUTHR

-$277.4M-237%

Viemed Healthcare, Inc.VMD

-$3.74M+49.3%

Other financials

Income statement

See full

Revenue$20.6M-8.7%

Gross profit$16.0M-1.8%

Operating income-$13.0M+11.0%

Net income-$13.7M+5.5%

EPS (diluted)-$0.33+8.3%

Balance sheet

See full

Cash & equivalents$61.0M-2.4%

Total debt$56.3M-1.2%

Total equity$45.8M-41.1%

Total assets$120.0M-20.4%

Cash flow

See full

Operating cash flow-$10.1M+23.6%

CapEx$9.0K-97.0%

Free cash flow-$10.1M+25.3%

Valuation

See full

Market cap$54.91M-47.3%

Enterprise value$50.17M-43.5%

P/S0.6×-0.5×

Profitability

See full

Gross margin75.5%+2.0pp

Operating margin-58.8%-5.8pp

Net margin-60.1%-4.4pp

FCF margin-33.2%-4.4pp

Returns & leverage

See full

Return on equity-86.2%+62.6pp

Debt / equity1.2×+0.5×

Current ratio4.9×-0.1×

Where this comes from

Reported directly by Pulmonx Corporation in its filing.

Tagged under the XBRL concept us-gaap:CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect.

The official record: Pulmonx Corporation’s 10-Q, filed May 4, 2026, on SEC EDGAR. View the filing →

Ask your AI about Pulmonx Corporation's net change in cash.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Claude

Questions, answered.

What is Pulmonx Corporation's net change in cash?: Pulmonx Corporation (LUNG) reported net change in cash of -$8.18M in Q1 2026.
How has Pulmonx Corporation's net change in cash changed year-over-year?: Pulmonx Corporation's net change in cash decreased by 324.1% year-over-year, from $3.65M to -$8.18M.
What is the long-term trend for Pulmonx Corporation's net change in cash?: Over 3 years (2021 to 2025), Pulmonx Corporation's net change in cash has grown at a -76.0% compound annual growth rate (CAGR), from -$83.08M to -$1.15M.
What does net change in cash mean?: Total increase or decrease in cash during the period — the sum of operating, investing, financing cash flows plus FX effects.